APOE and Alzheimer disease: To produce AD‐associated models, iPSCs containing FAD‐based genetic mutations or the SAD onset risk factor, the APOE4 allele, can be generated from AD patient cells or introduced using gene‐editing techniques such as CRISPR/Cas9.75